Announcements Trials
Browse Landscape

Status

Completed 4

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 38Observational 4Expanded_access 1

Sponsor

Cancer Type

Plasma cell 4Lymphoid 3Other hematologic neoplasm 1

Conditions

Multiple Myeloma 3Lymphoma 2Neoplasms, Plasma Cell 1

Interventions

Bortezomib 20Blood Specimen Collection 9Surveys and Questionnaires 8Lenalidomide 8Dexamethasone 8pomalidomide 6daratumumab 6Flow Cytometry 6Immunoenzyme Techniques 5Biopsy 5plerixafor 4idecabtagene vicleucel 4carfilzomib 4Standard of Care 4Polymerase Chain Reaction 4Amplified Fragment Length Polymorphism Analysis 4Specimen Handling 3Psychiatric Rehabilitation 3Patient Reported Outcome Measures 3Microarray Analysis 3Melphalan 3Magnetic Resonance Spectroscopy 3Interviews as Topic 3Drug Therapy 3Data Collection 3Cytogenetic Analysis 3Chromatin Immunoprecipitation Sequencing 3talquetamab 2selinexor 2belantamab mafodotin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × plerixafor × Plasma cell × Clear all
NCT03406091 2024-02-20

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Fondazione EMN Italy Onlus

Completed
300 enrolled
Plasma cell

Multiple Myeloma

NCT00741780 2015-03-24

Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).

Sanofi

Completed
164 enrolled
Plasma cell

Multiple Myeloma

NCT01738373 2015-03-23

Registry of Patients Treated With Plerixafor (Mozobil®) for Haematopoietic Stem Cell Mobilization Before Autologous Transplantation

Sanofi

Completed
262 enrolled
LymphoidPlasma cell

Lymphoma, Multiple Myeloma

NCT01700608 2012-10-04

Prospective Observational Study on Plerixafor After Chemotherapy

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Completed
27 enrolled
LymphoidPlasma cell

Lymphoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡